{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1452500",
  "DateCompleted": {
    "Year": "1993",
    "Month": "01",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0305-7453",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "3",
        "PubDate": {
          "Year": "1992",
          "Month": "Sep"
        }
      },
      "Title": "The Journal of antimicrobial chemotherapy",
      "ISOAbbreviation": "J Antimicrob Chemother"
    },
    "ArticleTitle": "Amoxycillin-resistant oral streptococci and experimental infective endocarditis in the rabbit.",
    "Pagination": {
      "StartPage": "349",
      "EndPage": "352",
      "MedlinePgn": "349-52"
    },
    "Abstract": {
      "AbstractText": [
        "The ability of three amoxycillin-resistant strains of Streptococcus sanguis 254, 24 and 297 (MIC 40 mg/L) to cause infective endocarditis (IE) in the rabbit was investigated. These strains all produced infection in the rabbit, as did an antibiotic sensitive control strain NCTC 7864. Prophylactic amoxycillin (400 mg/kg body weight) administered one hour before bacterial challenge prevented 80% of the animals developing IE irrespective of the challenging strain. It is concluded that amoxycillin-resistant strains of S. sanguis can cause IE and that amoxycillin prophylaxis can still be effective against these bacteria."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Dental Sciences, University of Liverpool, UK."
          }
        ],
        "LastName": "Longman",
        "ForeName": "L P",
        "Initials": "LP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Marsh",
        "ForeName": "P D",
        "Initials": "PD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Martin",
        "ForeName": "M V",
        "Initials": "MV"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Antimicrob Chemother",
    "NlmUniqueID": "7513617",
    "ISSNLinking": "0305-7453"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "804826J2HU",
      "NameOfSubstance": "Amoxicillin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Amoxicillin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ampicillin Resistance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Endocarditis, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rabbits"
    },
    {
      "QualifierName": [
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Streptococcal Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Streptococcus sanguis"
    }
  ]
}